COMSTOCK RESOURCES INC (CRK)

US2057683029 - Common Stock

10.15  +0.37 (+3.78%)

After market: 10.11 -0.04 (-0.39%)

Fundamental Rating

3

Taking everything into account, CRK scores 3 out of 10 in our fundamental rating. CRK was compared to 214 industry peers in the Oil, Gas & Consumable Fuels industry. There are concerns on the financial health of CRK while its profitability can be described as average. While showing a medium growth rate, CRK is valued expensive at the moment.



4

1. Profitability

1.1 Basic Checks

CRK had positive earnings in the past year.
In the past year CRK had a positive cash flow from operations.
In multiple years CRK reported negative net income over the last 5 years.
In the past 5 years CRK always reported a positive cash flow from operatings.

1.2 Ratios

CRK has a Return On Assets (5.53%) which is in line with its industry peers.
CRK's Return On Equity of 14.67% is in line compared to the rest of the industry. CRK outperforms 48.36% of its industry peers.
CRK's Return On Invested Capital of 5.57% is on the low side compared to the rest of the industry. CRK is outperformed by 67.14% of its industry peers.
CRK had an Average Return On Invested Capital over the past 3 years of 21.34%. This is significantly below the industry average of 45.80%.
The last Return On Invested Capital (5.57%) for CRK is well below the 3 year average (21.34%), which needs to be investigated, but indicates that CRK had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.53%
ROE 14.67%
ROIC 5.57%
ROA(3y)5.84%
ROA(5y)3.46%
ROE(3y)12.11%
ROE(5y)7.08%
ROIC(3y)21.34%
ROIC(5y)14.54%

1.3 Margins

With a Profit Margin value of 16.84%, CRK perfoms like the industry average, outperforming 51.17% of the companies in the same industry.
CRK has a Operating Margin (18.07%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CRK has declined.
CRK's Gross Margin of 56.93% is fine compared to the rest of the industry. CRK outperforms 60.09% of its industry peers.
In the last couple of years the Gross Margin of CRK has declined.
Industry RankSector Rank
OM 18.07%
PM (TTM) 16.84%
GM 56.93%
OM growth 3Y-8.67%
OM growth 5Y-19.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.8%
GM growth 5Y-6.83%

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CRK is creating value.
The number of shares outstanding for CRK has been increased compared to 1 year ago.
CRK has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CRK has a worse debt to assets ratio.

2.2 Solvency

CRK has an Altman-Z score of 1.14. This is a bad value and indicates that CRK is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.14, CRK is in line with its industry, outperforming 44.60% of the companies in the same industry.
A Debt/Equity ratio of 1.12 is on the high side and indicates that CRK has dependencies on debt financing.
CRK has a worse Debt to Equity ratio (1.12) than 74.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF N/A
Altman-Z 1.14
ROIC/WACC0.73
WACC7.62%

2.3 Liquidity

CRK has a Current Ratio of 0.68. This is a bad value and indicates that CRK is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.68, CRK is not doing good in the industry: 79.81% of the companies in the same industry are doing better.
A Quick Ratio of 0.68 indicates that CRK may have some problems paying its short term obligations.
The Quick ratio of CRK (0.68) is worse than 76.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.68

6

3. Growth

3.1 Past

CRK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -87.43%.
Measured over the past years, CRK shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.84% on average per year.
The Revenue for CRK has decreased by -51.05% in the past year. This is quite bad
Measured over the past years, CRK shows a very strong growth in Revenue. The Revenue has been growing by 32.02% on average per year.
EPS 1Y (TTM)-87.43%
EPS 3Y18.84%
EPS 5YN/A
EPS growth Q2Q-90.48%
Revenue 1Y (TTM)-51.05%
Revenue growth 3Y22.18%
Revenue growth 5Y32.02%
Revenue growth Q2Q-55.49%

3.2 Future

Based on estimates for the next years, CRK will show a very strong growth in Earnings Per Share. The EPS will grow by 71.48% on average per year.
CRK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.04% yearly.
EPS Next Y-86.06%
EPS Next 2Y62.04%
EPS Next 3Y53.29%
EPS Next 5Y71.48%
Revenue Next Year0.45%
Revenue Next 2Y17.72%
Revenue Next 3Y12.04%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.60, which indicates a rather expensive current valuation of CRK.
CRK's Price/Earnings ratio is a bit more expensive when compared to the industry. CRK is more expensive than 73.71% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.25. CRK is around the same levels.
The Price/Forward Earnings ratio is 154.97, which means the current valuation is very expensive for CRK.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRK indicates a slightly more expensive valuation: CRK is more expensive than 71.83% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.67, CRK is valued quite expensively.
Industry RankSector Rank
PE 21.6
Fwd PE 154.97

4.2 Price Multiples

60.09% of the companies in the same industry are more expensive than CRK, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.59

4.3 Compensation for Growth

A more expensive valuation may be justified as CRK's earnings are expected to grow with 53.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.04%
EPS Next 3Y53.29%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.41%, CRK is a good candidate for dividend investing.
CRK's Dividend Yield is a higher than the industry average which is at 5.79.
CRK's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 5.41%

5.2 History

CRK has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

40.17% of the earnings are spent on dividend by CRK. This is a bit on the high side, but may be sustainable.
DP40.17%
EPS Next 2Y62.04%
EPS Next 3Y53.29%

COMSTOCK RESOURCES INC

NYSE:CRK (4/24/2024, 7:04:00 PM)

After market: 10.11 -0.04 (-0.39%)

10.15

+0.37 (+3.78%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.95B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 5.41%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 21.6
Fwd PE 154.97
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 14.67%
ROCE
ROIC
ROICexc
ROICexgc
OM 18.07%
PM (TTM) 16.84%
GM 56.93%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.68
Quick Ratio 0.68
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-87.43%
EPS 3Y18.84%
EPS 5Y
EPS growth Q2Q
EPS Next Y-86.06%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-51.05%
Revenue growth 3Y22.18%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y